BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18046341)

  • 1. Identification of candidate genes that influence sex hormone-dependent disease phenotypes in mouse lupus.
    Gubbels Bupp MR; Jørgensen TN; Kotzin BL
    Genes Immun; 2008 Jan; 9(1):47-56. PubMed ID: 18046341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice.
    Rozzo SJ; Vyse TJ; David CS; Palmer E; Izui S; Kotzin BL
    J Immunol; 1999 Mar; 162(5):2623-30. PubMed ID: 10072504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormones and modulation of immune response in SLE.
    Talal N
    Clin Rheum Dis; 1982 Apr; 8(1):23-8. PubMed ID: 6749398
    [No Abstract]   [Full Text] [Related]  

  • 5. Autosomal loci associated with a sex-related difference in the development of autoimmune phenotypes in a lupus model.
    Misu N; Zhang M; Mori S; Miyazaki T; Furukawa H; Sasaki T; Nose M; Ono M
    Eur J Immunol; 2007 Oct; 37(10):2787-96. PubMed ID: 17823981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding.
    Nitschke L; Lajaunias F; Moll T; Ho L; Martinez-Soria E; Kikuchi S; Santiago-Raber ML; Dix C; Parkhouse RM; Izui S
    Int Immunol; 2006 Jan; 18(1):59-68. PubMed ID: 16291654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant interleukin-2 therapy of systemic lupus erythematosus in the New Zealand black/New Zealand white mouse.
    Owen KL; Shibata T; Izui S; Walker SE
    J Biol Response Mod; 1989 Aug; 8(4):366-74. PubMed ID: 2666586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of distinct immune components in the radiation-induced abrogation of systemic lupus erythematosus development in mice.
    e Brito RR; De Lorenzo BH; Xander P; Godoy LC; Lopes JD; da Silva NP; Sampaio SC; Mariano M
    Lupus; 2007; 16(12):947-54. PubMed ID: 18042588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval.
    Panchanathan R; Shen H; Bupp MG; Gould KA; Choubey D
    J Immunol; 2009 Dec; 183(11):7031-8. PubMed ID: 19890043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental use of murine lupus models.
    Peng SL
    Methods Mol Med; 2004; 102():227-72. PubMed ID: 15286389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus--recent clues from congenic strains.
    Henry T; Mohan C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):207-12. PubMed ID: 15995581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping BXSB congenic intervals, in combination with microarray gene expression, reveal novel lupus candidate genes.
    Haywood ME; Rose SJ; Horswell S; Lees MJ; Fu G; Walport MJ; Morley BJ
    Genes Immun; 2006 Apr; 7(3):250-63. PubMed ID: 16541099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant NZB contributions to lupus in the (SWR x NZB)F1 model.
    Xie S; Chang SH; Sedrak P; Kaliyaperumal A; Datta SK; Mohan C
    Genes Immun; 2002 Oct; 3 Suppl 1():S13-20. PubMed ID: 12215897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
    Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The New Zealand mouse as a model for the therapy of human SLE: immunomodulation of murine lupus by sex hormones and cyclophosphamide.
    Papoian R; Roubinian JR; Dauphinée MJ; Talal N
    Agents Actions Suppl; 1980; 7():41-5. PubMed ID: 6941685
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
    J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones and the genesis of autoimmunity.
    Ackerman LS
    Arch Dermatol; 2006 Mar; 142(3):371-6. PubMed ID: 16549717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male microbiota-associated metabolite restores macrophage efferocytosis in female lupus-prone mice via activation of PPARγ/LXR signaling pathways.
    Harder JW; Ma J; Alard P; Sokoloski KJ; Mathiowitz E; Furtado S; Egilmez NK; Kosiewicz MM
    J Leukoc Biol; 2023 Jan; 113(1):41-57. PubMed ID: 36822162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.